Atypical teratoid/rhabdoid tumor in adult: case series and an integrated survival analysis

Br J Neurosurg. 2024 Apr;38(2):425-432. doi: 10.1080/02688697.2021.1885620. Epub 2021 Feb 17.

Abstract

Background: Atypical teratoid/rhabdoid tumor (AT/RT) is well documented in children but less so in adults because of its rarity.

Method: We report a series of five cases, a literature review and quantitative analysis of the survival outcome of adult AT/RT patients.

Results: Seventy-four patients including our five cases (male: female = 16: 58) were evaluated, whose median age was 32.5 years (18-80 years). The commonest location was the sellar region. Median overall survival (OS) was 12.5 months (0.5-204.00 months). Chemotherapy was associated with OS (HR: 0.349, 95%CI: 0.176-0.694, p = 0.003), while other factors did not influence OS. From Kaplan-Meier analysis, surgery combining postoperative chemotherapy and radiotherapy was associated with better prognosis (Log Rank: χ2 = 14.662, p = 0.001).

Conclusions: Adult AT/RT is commoner in females and tends to recur rapidly after surgical resection. Chemotherapy may provide a survival benefit. Surgery combined with postoperative chemotherapy and radiotherapy was associated with better prognosis for adult AT/RT patients, though the overall prognosis was still poor.

Keywords: Atypical teratoid/rhabdoid tumor; chemotherapy; quantitative analysis; radiotherapy; surgery.

Publication types

  • Review

MeSH terms

  • Adult
  • Central Nervous System Neoplasms* / surgery
  • Child
  • Combined Modality Therapy
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasm Recurrence, Local
  • Rhabdoid Tumor* / surgery
  • Survival Analysis